Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Optic nerve regeneration requires the intracellular domain of LIFRα/CD118
Qian Jiang, Cong Wang, Yuerong Ren, Peiyun Duan, Ke Tian, Xiangwei Duan, Binghan Cai, Changzhong Xu, Ke Liu, Jian Li, Larry Benowitz, Ningli Wang, Bing Jiang, Lili Xie
Qian Jiang, Cong Wang, Yuerong Ren, Peiyun Duan, Ke Tian, Xiangwei Duan, Binghan Cai, Changzhong Xu, Ke Liu, Jian Li, Larry Benowitz, Ningli Wang, Bing Jiang, Lili Xie
View: Text | PDF
Research Article Neuroscience Ophthalmology

Optic nerve regeneration requires the intracellular domain of LIFRα/CD118

  • Text
  • PDF
Abstract

Identifying factors that govern the ability of retinal ganglion cells (RGCs) to extend axons is an important step in developing therapies to achieve recovery after optic nerve injury. Here, we report that the intracellular domain of the leukemia inhibitory factor receptor (LIFR/CD118) is essential for mature RGCs’ ability to regenerate injured axons independent of the cognate ligand (LIF) and other therapies. Overexpression of LIFR in adult RGCs induces neurite outgrowth in cultured RGCs and axon regeneration in vivo while strongly amplifying RGCs’ response to LIF itself and to unrelated growth factors. Conversely, downregulation of LIFR strongly suppresses the pro-regenerative effects of PTEN knockdown and other potent stimuli. LIFR modulation alters the constitutive activity of the MAPK pathway, in contrast to LIF itself, which primarily activates pSTAT3. The extracellular domain–truncated LIFR construct retains substantial pro-regenerative activity, whereas mutation of intracellular signaling motifs reduces the full regenerative effect of LIFR. Together, these findings identify LIFR as a key cell-autonomous regulator of optic nerve regeneration in mature RGCs.

Authors

Qian Jiang, Cong Wang, Yuerong Ren, Peiyun Duan, Ke Tian, Xiangwei Duan, Binghan Cai, Changzhong Xu, Ke Liu, Jian Li, Larry Benowitz, Ningli Wang, Bing Jiang, Lili Xie

×

Figure 2

LIFR overexpression promotes axon regeneration in the mature optic nerve.

Options: View larger image (or click on image) Download as PowerPoint
LIFR overexpression promotes axon regeneration in the mature optic nerve...
(A) Regenerating axons and RGC survival in whole-mounted retinas visualized by fluorescent CTB (green) and immunostaining against βIII-tubulin (red), respectively, 2 weeks after ONC with the indicated treatments. An asterisk indicates the injury site. Scale bar: 100 μm (left), 50 μm (right). This experiment was conducted twice. (B) Quantification of regenerating axons. Statistical significance was determined by unpaired 2-tailed t test (n.s. P > 0.05, ****P < 0.0001; n = 7–15 nerves per group). (C) Quantification of RGC survival. Statistical significance was determined by unpaired 2-tailed t test (n.s. P > 0.05; n = 7–16 eyes per group). (D) Representative images for regenerating axons and RGC survival in whole-mounted retinas with indicated treatment. The asterisk indicates the injury site. Scale bar: 100 μm (left), 50 μm (right). This experiment was conducted once. (E) Quantification of regenerating axons. Statistical significance was determined by unpaired 2-tailed t test (n.s. P > 0.05, ****P < 0.0001; n = 5–6 nerves per group). (F) Quantification of RGC survival. Statistical significance was determined by unpaired 2-tailed t test (n.s. P > 0.05; n = 5–6 eyes per group). Data represent mean ± SEM.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts